‘Forget forecasts – focus on quality’, says Claremont Global chief Bob Desmond

Bob Desmond is making his first appearance at the 2022 Sohn Hearts & Minds Conference.

Glenda Korporaal

‘Forget forecasts – focus on quality’, says Claremont Global chief Bob Desmond

October 24, 2022
Bob Desmond is making his first appearance at the 2022 Sohn Hearts & Minds Conference.
Read Transcript

Claremont Global head Bob Desmond says he learnt the importance of investing in quality companies when growing up in Zimbabwe during a time of hyperinflation.

“What I learned from that is no matter how bad economies get – and things got really bad in Zimbabwe – high-quality businesses which have high margins, strong balance sheets, strong cash flows and are capital-light can be very resilient,” he said in an interview with The Australian.

“I grew up in a world which was very uncertain, so I don’t try to predict the future."

“I just try to buy the highest-quality businesses. So, no matter what happens, you can protect capital for your clients.”

Desmond, who worked in London before moving to Australia in 2008, is making his first appearance at the annual Sohn Hearts & Minds Investment Leaders Conference, where fund managers give their favourite stock tips to raise money for medical research charities. The conference, which is now back to being held in person, will be in Hobart for the first time on Friday November 18.

Desmond oversees Claremont Global, a $1.2bn international investment fund which focuses its investment on 14 global companies, including LVMH, Nike, Visa, Alphabet, Microsoft, Adobe, Equifax and CME.

Desmond says he will recommend the one which is best priced at the time.

“We’ve got a small number of stocks which are all global leaders in their industry,” he says.

“They have higher than average revenue growth, higher than average margins, strong balance sheets and cash flow, good capital allocation by management and an understanding of their competitive advantage.”

The fund deliberately excludes investments in banks as well as companies in insurance, resources, oil and pharmaceuticals.

Desmond says his approach to investing is to not try to predict economic and market cycles.

He believes investors should give up pretending that they know what is going to happen to economies and look at the underlying quality of companies.

“I don’t know anyone who told me that the Fed would be as aggressive as it has been on rates this year,” he said.

“No one told me that there would be a pandemic and that governments would respond with a big amount of fiscal and monetary stimulus.”

Australian investors, he points out, would also have been misled had they banked on the comments by the Reserve Bank that it was not expecting to raise interest rates until 2024.

“The future is inherently unknowable,” he says.

Claremont, he explains, looks for companies with growth opportunities, and never buys a stock just because it is cheap.

Desmond likes high-quality companies as they can ride out economic cycles.

Luxury brand company LVMH, which owns a range of global brands including Christian Dior, Sephora, Moet & Chandon, Krug, Hennessy, Fendi, Givenchy and Bulgari, is growing strongly despite talk of recession.

While its sales in China are down, because of the downturn in its economy, the company is seeing strong growth in the US.

“It’s a really strong line-up of brands and amazing management which has been in place for more than 30 years,” Desmond says.

Visa, he says, is benefiting from the resumption of global travel.

Despite concerns about the prospects of a recession, Desmond says consumer spending is still holding up well globally.

He believes that good brands will outperform in a downturn.

One less well known company he holds is Zoetis, the world’s largest producer of medicine and vaccines for animals and livestock, which was spun off from Pfizer.

Desmond sees the company’s growth driven by increasing spending on pet care.

Claremont has a global watch list of about 120 stocks, with an approved list of about 40.

Unlike some other funds focused on international investing, such as Platinum Asset Management and Magellan, Claremont has avoided any investment in Chinese stocks.

Desmond says he looked at investing in e-commerce giant Alibaba but decided against it because of the uncertainty over shareholder protection for Chinese stocks.

Most of Claremont’s stocks are based in the US, a market where he says there are still good global companies that are undervalued compared to their peers in Australia and Europe.

Desmond says another lesson he has learned in his investing career is to “try and be more of an optimist” when it comes to the sharemarket.

“I’ve always been on the bearish side of life,” he says.

“The Asian crisis was pretty scary, the dot.com crisis was scary, the Global Financial Crisis was petrifying. And then we had Brexit and Trump and Covid-19.

“These events have all happened. But what has come out, over time, is that if you buy good businesses, their earnings are growing and you take a long-term view, you are going to get a good return from your investments.”

The Sohn Hearts & Minds Investment Leaders Conference is an annual one-day event which brings the investment community together in support of Australian medical research.

It was held on Friday 18 November, Sohn Hearts & Minds in Hobart, with support from the Tasmanian government.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Claremont Global head Bob Desmond says he learnt the importance of investing in quality companies when growing up in Zimbabwe during a time of hyperinflation.

“What I learned from that is no matter how bad economies get – and things got really bad in Zimbabwe – high-quality businesses which have high margins, strong balance sheets, strong cash flows and are capital-light can be very resilient,” he said in an interview with The Australian.

“I grew up in a world which was very uncertain, so I don’t try to predict the future."

“I just try to buy the highest-quality businesses. So, no matter what happens, you can protect capital for your clients.”

Desmond, who worked in London before moving to Australia in 2008, is making his first appearance at the annual Sohn Hearts & Minds Investment Leaders Conference, where fund managers give their favourite stock tips to raise money for medical research charities. The conference, which is now back to being held in person, will be in Hobart for the first time on Friday November 18.

Desmond oversees Claremont Global, a $1.2bn international investment fund which focuses its investment on 14 global companies, including LVMH, Nike, Visa, Alphabet, Microsoft, Adobe, Equifax and CME.

Desmond says he will recommend the one which is best priced at the time.

“We’ve got a small number of stocks which are all global leaders in their industry,” he says.

“They have higher than average revenue growth, higher than average margins, strong balance sheets and cash flow, good capital allocation by management and an understanding of their competitive advantage.”

The fund deliberately excludes investments in banks as well as companies in insurance, resources, oil and pharmaceuticals.

Desmond says his approach to investing is to not try to predict economic and market cycles.

He believes investors should give up pretending that they know what is going to happen to economies and look at the underlying quality of companies.

“I don’t know anyone who told me that the Fed would be as aggressive as it has been on rates this year,” he said.

“No one told me that there would be a pandemic and that governments would respond with a big amount of fiscal and monetary stimulus.”

Australian investors, he points out, would also have been misled had they banked on the comments by the Reserve Bank that it was not expecting to raise interest rates until 2024.

“The future is inherently unknowable,” he says.

Claremont, he explains, looks for companies with growth opportunities, and never buys a stock just because it is cheap.

Desmond likes high-quality companies as they can ride out economic cycles.

Luxury brand company LVMH, which owns a range of global brands including Christian Dior, Sephora, Moet & Chandon, Krug, Hennessy, Fendi, Givenchy and Bulgari, is growing strongly despite talk of recession.

While its sales in China are down, because of the downturn in its economy, the company is seeing strong growth in the US.

“It’s a really strong line-up of brands and amazing management which has been in place for more than 30 years,” Desmond says.

Visa, he says, is benefiting from the resumption of global travel.

Despite concerns about the prospects of a recession, Desmond says consumer spending is still holding up well globally.

He believes that good brands will outperform in a downturn.

One less well known company he holds is Zoetis, the world’s largest producer of medicine and vaccines for animals and livestock, which was spun off from Pfizer.

Desmond sees the company’s growth driven by increasing spending on pet care.

Claremont has a global watch list of about 120 stocks, with an approved list of about 40.

Unlike some other funds focused on international investing, such as Platinum Asset Management and Magellan, Claremont has avoided any investment in Chinese stocks.

Desmond says he looked at investing in e-commerce giant Alibaba but decided against it because of the uncertainty over shareholder protection for Chinese stocks.

Most of Claremont’s stocks are based in the US, a market where he says there are still good global companies that are undervalued compared to their peers in Australia and Europe.

Desmond says another lesson he has learned in his investing career is to “try and be more of an optimist” when it comes to the sharemarket.

“I’ve always been on the bearish side of life,” he says.

“The Asian crisis was pretty scary, the dot.com crisis was scary, the Global Financial Crisis was petrifying. And then we had Brexit and Trump and Covid-19.

“These events have all happened. But what has come out, over time, is that if you buy good businesses, their earnings are growing and you take a long-term view, you are going to get a good return from your investments.”

The Sohn Hearts & Minds Investment Leaders Conference is an annual one-day event which brings the investment community together in support of Australian medical research.

It was held on Friday 18 November, Sohn Hearts & Minds in Hobart, with support from the Tasmanian government.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Oct 24, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Martin Hughes founder of UK-based Toscafund. Picture: Elke MeitzelMartin Hughes founder of UK-based Toscafund. Picture: Elke MeitzelMartin Hughes founder of UK-based Toscafund. Picture: Elke MeitzelMartin Hughes founder of UK-based Toscafund. Picture: Elke Meitzel
November 16, 2023

Hedge Fund Veteran Talks Lowest Moment In Toscafund’s 23-Year Run

Most hedge fund managers brag about their wins and shy away from their losses – Martin Hughes is not most hedge fund managers.

Read More
November 16, 2023

The ‘Armageddon Scenario’ Worrying The Future Fund CIO

Mr Samild shared his thoughts on the bond market – which underpins the returns of other assets – ahead of his appearance at Friday’s Sohn Hearts & Minds charity conference at the Sydney Opera House.

Read More
Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.
November 15, 2023

Advancing Medicine Is In Daniel MacArthur’s DNA

When genomic scientist Daniel MacArthur had the opportunity to set up a new Centre for Population Genomics in Australia in 2019, he jumped at the chance to return home after 12 years living overseas.

Read More
November 15, 2023

Ashish Swarup - Invest In Snacks, Let's Get That Bread | Aikya Investment Management

Ashish Swarup, Portfolio Manager and Investment Analyst of Aikya Investment Management joins Bryce and Ren to discuss emerging markets, and two stock deep dives.

Read More
Surging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFP
November 15, 2023

Daniel Loeb’s Wall St Hedge Fund Third Point Raises Bets On Corporate Credit Crunch

An “obsession” around balance sheet strength and debt is creating a new wave of investment bets for the influential Wall Street hedge fund run by Daniel Loeb.

Read More
November 13, 2023

Bond Bullish On Commodity Stocks, Uranium

Mining stocks are poised to rise amid tight supply for key commodities such as copper, nickel and uranium, says Terra Capital founder Jeremy Bond.

Read More
November 13, 2023

This Hedge Fund Manager Is Making A 100-Year Bet On Luxury

European leisure and luxury – a designer handbag, a last-minute flight to Monte Carlo, a stay in a five-star hotel – is where many choose to spend their hard-earned cash. For Sharif el Khazen, it’s where he makes it.

Read More
Munro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki Connolly
November 12, 2023

How Munro Will Pick Its Next Stock Winner

Munro partner and portfolio manager Kieran Moore must select a single company to pitch to an audience of industry heavyweights at the prestigious Sohn Hearts & Minds conference in Sydney.

Read More
Ray Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: Bloomberg
November 12, 2023

The Australian At The Centre Of Dalio’s Bridgewater – Who Loves It

The culture at Ray Dalio’s massive hedge fund has been a source of intrigue, and with a new book, controversy. Atul Lele says it’s made him a better investor.

Read More
Sheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic Lorrimer
November 10, 2023

Meet The Goldman Sachs Legend Shaking Up Venture Capital

Sheila Patel says it was time for the venture capital sector to “grow up” and higher rates will help do that job. VC firms need to think differently about how they invest.

Read More
November 8, 2023

Tom Naughton - There's Money In Mi Goreng | Prusik Investment

Tom Naughton is Managing Partner and CIO at Prusik Investment. In this episode, he chats to Equity Mates ahead of his appearance at the 2023 Sohn Hearts and Minds Conference.

Read More
November 6, 2023

Why Chris Kourtis just bought CSL and ResMed

A true contrarian investor, Chris Kourtis can find himself sounding a lot like a bull when in the company of bears, and there’s a lot to be bearish about at the moment.

Read More
Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.
November 5, 2023

Five Secrets To Delivering The Perfect Pitch

Australia’s best stock pickers have just eight minutes to convince the country’s top money managers they have found an investment gem that the market has overlooked.

Read More
Picture: Solomon Lew & David ParadicePicture: Solomon Lew & David ParadicePicture: Solomon Lew & David ParadicePicture: Solomon Lew & David Paradice
November 3, 2023

Paradice and Lew on their love of medical research – and Greece

Solomon Lew, the billionaire retailer, has known David Paradice, the high-profile fund managers, for years. Beyond investing, they share a common interest in medical research – and holidaying in Greece.

Read More
November 2, 2023

Meet the 2023 Conference Managers

Following a rigorous global search, the Conference Fund Manager Selection Committee is pleased to share ten new managers for 2023.

Read More